Retraction Watch

Tracking retractions as a window into the scientific process

Weekend reads, part 2: Oldest-ever PhD; most embarrassing citation ever; blame the antibodies?

with 2 comments

booksAs we noted Saturday, there was so much happening around the web last week that it made sense to break up Weekend Reads, especially since this is a holiday weekend in the U.S. and elsewhere. Here’s part 2:

Like Retraction Watch? Consider supporting our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, and sign up on our homepage for an email every time there’s a new post.

Written by Ivan Oransky

May 25th, 2015 at 9:30 am

Posted in weekend reads

Comments
  • John Mashey May 25, 2015 at 11:50 am

    Thanks for the note above on $2M lawsuit,, which fortunately did not get very far.

    For RW though, more relevant is the history:
    1) Between George Mason U’s Ed Wegman, his asscoaite Yamsin Said, and some of his students, about 100 pages of plagiarism have been documented and reported. THis was n’t subtle, but pathwritten copy-paste-edit, typically with 50% word-for-word copied, maybe 20% trivial edits, and 30% original or unidentified.

    2) GMU rejected or ignored or ignroed all of this except onhe article that had been retracted for plagiarism already.

    3) Wegman and Said wrote 2 such articles for WIley’s WIREs:Computational Statistics, which they co-edit. Said was also using a false rank/affiliation (Professor Oklahoma State University) on the masthead. All this was reported to Wiley, who basically stonewalled, and then let them replace the articles, with no admission of any problems and minimal notice.

    4) Eventually, although unclear why, Wiley forced their resignation June 2012.

    5) In mid 2014, they launched lawsuits, but didn’t bother to tell me until March 2015.
    Five weeks later the case was over, as they voluntarily dismissed it.

    Wiley’s behavior was very strange.

  • BB May 25, 2015 at 3:17 pm

    Low quality polyclonal ABs sometimes produced in substandard facilities are definitely a menace. The same can be said about a number of “selective” receptor agonist/antagonist small molecules and peptides (subtle cytotoxicity, massive off-target effects).

  • Post a comment

    Threaded commenting powered by interconnect/it code.